Xencor Reports Second Quarter 2019 Financial Results

Go back to Xencor Reports Second Quarter 2019 Financial Results

Xencor (XNCR) Tops Q2 EPS by 18c, Revenues Beat

August 6, 2019 5:16 PM EDT

Xencor (NASDAQ: XNCR) reported Q2 EPS of ($0.28), $0.18 better than the analyst estimate of ($0.46). Revenue for the quarter came in at $19.5 million versus the consensus estimate of $7.64 million.

Over the last two years, Xencor has initiated six Phase 1 clinical studies evaluating XmAb® bispecific antibodiesboth T cell engagers and tumor... More